PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
- Previous Close
334.00 - Open
336.00 - Bid 338.00 x --
- Ask 332.00 x --
- Day's Range
322.00 - 338.00 - 52 Week Range
160.00 - 436.00 - Volume
3,008,900 - Avg. Volume
6,464,588 - Market Cap (intraday)
420B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
6.48 - EPS (TTM)
51.84 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 6, 2021
- 1y Target Est
--
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
diagnos.co.id64
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: DGNS.JK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DGNS.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DGNS.JK
Valuation Measures
Market Cap
420.00B
Enterprise Value
420.00B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.37%
Return on Assets (ttm)
-3.70%
Return on Equity (ttm)
-6.73%
Revenue (ttm)
145.7B
Net Income Avi to Common (ttm)
-13.66B
Diluted EPS (ttm)
51.84
Balance Sheet and Cash Flow
Total Cash (mrq)
11.94B
Total Debt/Equity (mrq)
27.97%
Levered Free Cash Flow (ttm)
-17.95B
Company Insights: DGNS.JK
DGNS.JK does not have Company Insights